0000899243-21-005753.txt : 20210210
0000899243-21-005753.hdr.sgml : 20210210
20210210192222
ACCESSION NUMBER: 0000899243-21-005753
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210208
FILED AS OF DATE: 20210210
DATE AS OF CHANGE: 20210210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ARCH Venture Fund X, L.P.
CENTRAL INDEX KEY: 0001757011
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39941
FILM NUMBER: 21615850
BUSINESS ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD, SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
BUSINESS PHONE: 773-380-6600
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD, SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CRANDELL KEITH
CENTRAL INDEX KEY: 0001219039
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39941
FILM NUMBER: 21615851
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BYBEE CLINTON
CENTRAL INDEX KEY: 0001219043
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39941
FILM NUMBER: 21615852
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burow Kristina
CENTRAL INDEX KEY: 0001569248
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39941
FILM NUMBER: 21615853
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GILLIS STEVEN
CENTRAL INDEX KEY: 0001229592
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39941
FILM NUMBER: 21615854
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sana Biotechnology, Inc.
CENTRAL INDEX KEY: 0001770121
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 188 EAST BLAINE STREET, SUIT 400
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: (206) 701-7914
MAIL ADDRESS:
STREET 1: 188 EAST BLAINE STREET, SUIT 400
CITY: SEATTLE
STATE: WA
ZIP: 98102
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-08
0
0001770121
Sana Biotechnology, Inc.
SANA
0001757011
ARCH Venture Fund X, L.P.
8755 WEST HIGGINS ROAD
SUITE 1025
CHICAGO
IL
60631
0
0
1
0
0001219039
CRANDELL KEITH
8755 WEST HIGGINS ROAD, SUITE 1025
CHICAGO
IL
60631
0
0
1
0
0001219043
BYBEE CLINTON
8755 WEST HIGGINS ROAD, SUITE 1025
CHICAGO
IL
60631
0
0
1
0
0001569248
Burow Kristina
8755 WEST HIGGINS ROAD, SUITE 1025
CHICAGO
IL
60631
0
0
1
0
0001229592
GILLIS STEVEN
8755 WEST HIGGINS ROAD, SUITE 1025
CHICAGO
IL
60631
0
0
1
0
Common Stock
2021-02-08
4
C
0
10156250
A
10303750
I
See Footnotes
Common Stock
2021-02-08
4
C
0
10156250
A
10301250
I
See Footnotes
Common Stock
2021-02-08
4
C
0
11718750
A
11718750
I
See Footnotes
Common Stock
2021-02-08
4
C
0
11718750
A
11718750
I
See Footnotes
Series A-1 Convertible Preferred Stock
2021-02-08
4
C
0
3687500
0.00
D
Common Stock
3687500
0
I
See Footnotes
Series A-1 Convertible Preferred Stock
2021-02-08
4
C
0
3687500
0.00
D
Common Stock
3687500
0
I
See Footnotes
Series A-2 Convertible Preferred Stock
2021-02-08
4
C
0
5687500
0.00
D
Common Stock
5687500
0
I
See Footnotes
Series A-2 Convertible Preferred Stock
2021-02-08
4
C
0
9375000
0.00
D
Common Stock
9375000
0
I
See Footnotes
Series A-2 Convertible Preferred Stock
2021-02-08
4
C
0
9375000
0.00
D
Common Stock
9375000
0
I
See Footnotes
Series A-2 Convertible Preferred Stock
2021-02-08
4
C
0
5687500
0.00
D
Common Stock
5687500
0
I
See Footnotes
Series B Convertible Preferred Stock
2021-02-08
4
C
0
781250
0.00
D
Common Stock
781250
0
I
See Footnotes
Series B Convertible Preferred Stock
2021-02-08
4
C
0
781250
0.00
D
Common Stock
781250
0
I
See Footnotes
Series B Convertible Preferred Stock
2021-02-08
4
C
0
2343750
0.00
D
Common Stock
2343750
0
I
See Footnotes
Series B Convertible Preferred Stock
2021-02-08
4
C
0
2343750
0.00
D
Common Stock
2343750
0
I
See Footnotes
The shares of Issuer's Preferred Stock automatically converted into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering.
Represents shares held directly by ARCH Venture Fund IX, L.P. (ARCH IX). ARCH Venture Partners IX, L.P. (AVP IX LP) is the sole general partner of ARCH IX.
Represents shares held directly by ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage). ARCH Venture Partners IX Overage, L.P. (AVP IX Overage LP) is the sole general partner of ARCH IX Overage.
ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein.
Represents shares held directly by ARCH Venture Fund X, L.P. (ARCH X). ARCH Venture Partners X, L.P. (AVP X LP) is the sole general partner of ARCH X.
Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage). ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage.
ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of each of AVP X LP and AVP X Overage LP. Keith Crandell, Kristina Burow and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X LP and AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, respectively, AVP X LLC may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X and ARCH X Overage. AVP X LP, AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein.
The expiration date is not relevant to the conversion of these securities.
Form 2 of 2.
/s/ Keith Crandell, By: Mark McDonnell, attorney in-fact
2021-02-10
/s/ Clinton Bybee, By: Mark McDonnell, attorney in-fact
2021-02-10
/s/ Kristina Burow, By: Mark McDonnell, attorney in-fact
2021-02-10
/s/ Steven Gillis, By: Mark McDonnell, attorney in-fact
2021-02-10